PTK2 and leukemia: Only one study mentions the fact that FAK+ AML-derived BMSCs have a decreased clonogenic activity due to an increased senescence [32], but there is no direct evidence showing that FAK abnormal expression in BMSCs contributes to leukaemia development and by which mechanism.